Logo
x

Search

Subscribe Now

RadioMedix

RadioMedix and Orano Med’s AlphaMedix Receives the US FDA’s Breakthrough Therapy Designation for Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

RadioMedix and Orano Med’s AlphaMedix Receives the US FDA’s Breakthrough Therapy Designation for Gastroenteropancreatic Neuroendoc...

  • February 13, 2024
Insights+: The US FDA New Drug Approvals in September 2020

Insights+: The US FDA New Drug Approvals in September 2020

  • October 15, 2020
RadioMedix and Curium Detectnet (copper Cu 64 dotatate injection) Receives US FDA's Approval for Positive Neuroendocrine Tumors (NETs)

RadioMedix and Curium Detectnet (copper Cu 64 dotatate injection) Receives US FDA's Approval for Positive Neuroendocrine Tumors (N...

  • September 3, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.